Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-003640
Filing Date
2013-01-23
Accepted
2013-01-23 16:47:10
Documents
1
Period of Report
2013-01-18

Document Format Files

Seq Description Document Type Size
1 form326641_20130123044542-.html 3  
1 form326641_20130123044542-.xml 3 6633
  Complete submission text file 0001144204-13-003640.txt   8170
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 667 MADISON AVE. 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE. 21ST FLOOR NEW YORK NY 10065 212-339-5600
14159, L.P. (Reporting) CIK: 0001551138 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 13543227